Emergent BioSolutions Inc

NYSE:EBSHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$6.29−1.10%At closeAt close · Tue 20 Oct · ≈ AED 23.10 · Market cap $322.51M · Next earnings Wed 28 Oct

USD billions	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	YoY
Cash & cash equivalents	0.6	0.6	0.6	0.1	0.1	0.2	+106.4%
Cash & short-term investments	0.6	0.6	0.6	0.1	0.1	0.2	+106.4%
Receivables	0.2	0.3	0.2	0.2	0.2	0.1	−45.5%
Inventory	0.3	0.3	0.4	0.3	0.3	0.3	+10.2%
Total current assets	1.2	1.3	1.2	0.7	0.6	0.7	+10.7%
Property, plant & equipment	0.7	0.8	0.8	0.4	0.3	0.2	−24.1%
Goodwill & intangibles	0.9	0.8	0.9	0.6	0.5	0.4	−13.0%
Long-term investments	0.0	0.0	0.0	0.0	0.0	0.0	—
Total assets	2.9	3.0	3.2	1.8	1.4	1.3	−5.1%
Payables	0.1	0.1	0.1	0.1	0.1	0.1	−8.7%
Short-term debt	0.0	0.0	1.0	0.4	0.0	0.0	−100.0%
Total current liabilities	0.4	0.4	1.2	0.7	0.2	0.1	−18.6%
Long-term debt	0.9	0.8	0.4	0.4	0.7	0.6	−13.8%
Total debt	0.9	0.9	1.4	0.9	0.7	0.6	−15.4%
Net debt	0.3	0.3	0.8	0.7	0.6	0.4	−36.4%
Deferred revenue	0.0	0.0	0.0	0.0	0.0	0.0	—
Total liabilities	1.4	1.3	1.8	1.2	0.9	0.8	−12.2%
Total equity	1.4	1.6	1.4	0.6	0.5	0.5	+8.2%
Retained earnings	0.7	1.0	0.7	(0.0)	(0.2)	(0.2)	+24.8%

USD billionsUpdated Thu 6 Aug ·

ⓘ

Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.